Skip to content
Open access · CC-BY via OpenAlex

The gut microbiome dysbiosis and regulation by fecal microbiota transplantation: umbrella review

Xianzhuo Zhang, Xufei Luo, Tian Gang Liang, Ping Yue, Mengyao Li, Kefeng Liu, Daoming Zhu, Chongfei Huang, Qianling Shi, Liping Yang, Zhili Xia, Jinyu Zhao, Zelong Ma, Jianlong Li, Joseph W. Leung

Frontiers in Microbiology · 2023 · ▲ 39 citations

Abstract

Background Gut microbiome dysbiosis has been implicated in various gastrointestinal and extra-gastrointestinal diseases, but evidence on the efficacy and safety of fecal microbiota transplantation (FMT) for therapeutic indications remains unclear. Methods The gutMDisorder database was used to summarize the associations between gut microbiome dysbiosis and diseases. We performed an umbrella review of published meta-analyses to determine the evidence synthesis on the efficacy and safety of FMT in treating various diseases. Our study was registered in PROSPERO (CRD42022301226). Results Gut microbiome dysbiosis was associated with 117 gastrointestinal and extra-gastrointestinal. Colorectal cancer was associated with 92 dysbiosis. Dysbiosis involving Firmicutes (phylum) was associated with 34 diseases. We identified 62 published meta-analyses of FMT. FMT was found to be effective for 13 diseases, with a 95.56% cure rate (95% CI: 93.88–97.05%) for recurrent Chloridoids difficile infection (rCDI). Evidence was high quality for rCDI and moderate to high quality for ulcerative colitis and Crohn’s disease but low to very low quality for other diseases. Conclusion Gut microbiome dysbiosis may be implicated in numerous diseases. Substantial evidence suggests FMT improves clinical outcomes for certain indications, but evidence quality varies greatly depending on the specific indication, route of administration, frequency of instillation, fecal preparation, and donor type. This variability should inform clinical, policy, and implementation decisions regarding FMT.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3389/fmicb.2023.1286429
Canonical
link ↗
Fetched
2026-11-12 MST

Cite this

APA
Zhang, X., Luo, X., Liang, T.G., Yue, P., Li, M., Liu, K., Zhu, D., Huang, C., Shi, Q., Yang, L., Xia, Z., Zhao, J., Ma, Z., Li, J., Leung, J.W., Lin, Y., Yuan, J., Meng, W., Li, X., &amp; Chen, Y. (2023). The gut microbiome dysbiosis and regulation by fecal microbiota transplantation: umbrella review. <em>Frontiers in Microbiology</em>. https://doi.org/10.3389/fmicb.2023.1286429
Vancouver
Zhang X, Luo X, Liang TG, Yue P, Li M, Liu K, et al. The gut microbiome dysbiosis and regulation by fecal microbiota transplantation: umbrella review. Frontiers in Microbiology. 2023. doi:10.3389/fmicb.2023.1286429.
BibTeX
@article{xianzhuo2023Thegut, title = {The gut microbiome dysbiosis and regulation by fecal microbiota transplantation: umbrella review}, author = {Xianzhuo Zhang and Xufei Luo and Tian Gang Liang and Ping Yue and Mengyao Li and Kefeng Liu and Daoming Zhu and Chongfei Huang and Qianling Shi and Liping Yang and Zhili Xia and Jinyu Zhao and Zelong Ma and Jianlong Li and Joseph W. Leung and Yanyan Lin and Jinqiu Yuan and Wenbo Meng and Xun� Li and Yaolong Chen}, journal = {Frontiers in Microbiology}, year = {2023}, doi = {10.3389/fmicb.2023.1286429}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings